PorMedTec, Inc.

Building a supply of organs for transplant research

PorMedTec uses cloning technology to reproduce gene-edited donor pigs developed by eGenesis. The genetic modifications are designed to reduce immune rejection and address the risk of porcine endogenous retrovirus transmission when organs are transplanted into people.

The Kawasaki company is preparing Japanese kidney-transplant trials with Hokkaido University Hospital and Shonan Kamakura General Hospital. As of September 2026, it was producing donor pigs for the studies and targeting a 2028 trial start, with surgeons already practicing organ-retrieval and transplant procedures.